Chemically defined generation of human cardiomyocytes

Burridge, Paul W, Matsa, Elena, Shukla, Praveen, Lin, Ziliang C, Churko, Jared M, Ebert, Antje D, Lan, Feng, Diecke, Sebastian +7 more·2014·Nature Methods

Cited by (1,001)

Items 501–600 of 1,001

  1. Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity
    Danyu Ye, Zhengyi Bao, Yu Pu Yang, Zhenbo Han, Ying Yu, Zihang Xu, Wenya Ma, Ye Yuan, Lai Zhang, Yan Xu et al. · 2020 · Toxicology
  2. Development of new adeno-associated virus capsid variants for targeted gene delivery to human cardiomyocytes
    Cindy Y. Kok, Shinya Tsurusaki, Marti Cabanes-Creus, S. Igoor, R. Rao, R. Skelton, S. H. Liao, S. Ginn, Maddison Knight, S. Scott et al. · 2023 · Molecular Therapy: Methods & Clinical Development
  3. GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes
    S. Tuuli Karhu, Sini M. Kinnunen, Marja Tölli, Mika J. Välimäki, Zoltán Szabó, Virpi Talman, Heikki J Ruskoaho · 2020 · Archives of Toxicology
  4. Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs
    Agapios Sachinidis · 2020 · Cells
  5. Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
    Feixiang Ge, Zetian Wang, Jianzhong Xi · 2019 · Cells
  6. Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions
    Sherri M. Biendarra‐Tiegs, Daniel J. Clemens, Frank J. Secreto, Timothy J. Nelson · 2019 · Stem Cells and Development
  7. Silver nanoparticles (AgNPs) and AgNO3 perturb the specification of human hepatocyte-like cells and cardiomyocytes
    Bowen Hu, Nuoya Yin, Renjun Yang, Shengxian Liang, Shaojun Liang, Francesco Faiola · 2020 · The Science of The Total Environment
  8. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies
    Chrishan J. A. Ramachandra, Jasper Chua, Shuo Cong, K.P. Myu Mai Ja, WINSTON S. N. SHIM, Joseph C. Wu, Derek John Hausenloy · 2020 · Cardiovascular Research
  9. Fibronectin-based nanomechanical biosensors to map 3D surface strains in live cells and tissue
    Daniel John Shiwarski, Joshua W. Tashman, Alkiviadis Tsamis, Jaci M. Bliley, Malachi A. Blundon, Edgar C. Aranda-Michel, Quentin Jallerat, John M. Szymanski, Brooke M. McCartney, Adam W. Feinberg · 2020 · Nature Communications
  10. Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes
    Hiroyuki Inoue, Satoki Nakamura, Shuichiro Higo, Mikio Shiba, Yasuaki Kohama, Takumi Kondo, Satoshi Kameda, Tomoka Tabata, Shota Okuno, Yoshihiko Ikeda et al. · 2022 · Stem Cell Reports
  11. Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy
    Robin Duelen, Domiziana Costamagna, Guillaume Gilbert, Liesbeth De Waele, Nathalie Goemans, Kaat Desloovere, Catherine M. Verfaillie, Karin R. Sipido, Gunnar Buyse, Maurilio Sampaolesi · 2022 · Stem Cell Reports
  12. Activation of PDGFRA signaling contributes to filamin C–related arrhythmogenic cardiomyopathy
    Suet Nee Chen, Chi Keung Lam, Ying‐Wooi Wan, Shanshan Gao, Olfat A. Malak, Shane Rui Zhao, Raffaella Lombardi, Amrut V. Ambardekar, Michael R. Bristow, Joseph C. Cleveland et al. · 2022 · Science Advances
  13. Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols
    Dorota Jeziorowska, Vincent Fontaine, Charlène Jouve, Eric Villard, Sébastien Dussaud, David Akbar, Valérie Letang, Pauline Cervello, Jean-Michiel Itier, Marie‐Pierre Pruniaux et al. · 2017 · International Journal of Molecular Sciences
  14. BART-Seq: cost-effective massively parallelized targeted sequencing for genomics, transcriptomics, and single-cell analysis
    Uzbas, Fatma, Opperer, Florian, Sönmezer, Can, Shaposhnikov, Dmitry, Sass, Steffen, Krendl, Christian, Angerer, Philipp, Theis, Fabian J., Mueller, Nikola S., Drukker, Micha · 2019 · Genome Biology
  15. Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes
    Benjamin B. Johnson, Marie‐Victoire Cosson, Lorenza Iolanda Tsansizi, Terri L. Holmes, Tegan Gilmore, Katherine Hampton, Ok‐Ryul Song, Nguyen T.N. Vo, Aishah Nasir, Alzbeta Chabronova et al. · 2024 · Cell Reports
  16. Generation of Functional Cardiomyocytes from Efficiently Generated Human iPSCs and a Novel Method of Measuring Contractility
    Sheeja Rajasingh, Jayakumar Thangavel, András Czirók, Saheli Samanta, Katherine F. Roby, Buddhadeb Dawn, Johnson Rajasingh · 2015 · PLoS ONE
  17. Defined three-dimensional culture conditions mediate efficient induction of definitive endoderm lineage from human umbilical cord Wharton’s jelly mesenchymal stem cells
    Ashraf Said Al Madhoun, Hamad Ali, Sarah Al-Kandari, Valerie Atizado, Nadeem Akhter, Fahd Al‐Mulla, Maher Atari · 2016 · Stem Cell Research & Therapy
  18. Developing a Cost-Effective and Scalable Production of Human Hepatic Competent Endoderm from Size-Controlled Pluripotent Stem Cell Aggregates
    Zahra Farzaneh, Mostafa Najarasl, Saeed Abbasalizadeh, Massoud Vosough, Hossein Baharvand · 2018 · Stem Cells and Development
  19. hiPSCs in cardio-oncology: deciphering the genomics
    Emily A. Pinheiro, K. Ashley Fetterman, Paul W. Burridge · 2019 · Cardiovascular Research
  20. SWI/SNF Component BAF250a Coordinates OCT4 and WNT Signaling Pathway to Control Cardiac Lineage Differentiation
    Ienglam Lei, Shuo Tian, Victor Chen, Yong Bo Zhao, Zhong Wang · 2020 · Frontiers in Cell and Developmental Biology
  21. Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4
    Pelin Arabacilar Golforoush, Priyanka Narasimhan, Patricia Cháves, Elsa Lawrence, Gary K. Newton, Robert Yan, Siân E. Harding, Trevor R. Perrior, Kathryn L. Chapman, Michael D. Schneider · 2020 · Scientific Reports
  22. Highly purified extracellular vesicles from human cardiomyocytes demonstrate preferential uptake by human endothelial cells
    Limor Zwi‐Dantsis, Charles W. Winter, Ulrike Kauscher, Arianna Ferrini, Brian Wang, Thomas E. Whittaker, Steve R. Hood, Cesare M. Terracciano, Molly M. Stevens · 2020 · Nanoscale
  23. iPSC-Cardiomyocyte Models of Brugada Syndrome—Achievements, Challenges and Future Perspectives
    Aleksandra Nijak, Johan B. Saenen, Alain J. Labro, Dorien Schepers, Bart Loeys, Maaike Alaerts · 2021 · International Journal of Molecular Sciences
  24. Mending a broken heart: In vitro, in vivo and in silico models of congenital heart disease
    A. J. Rufaihah, Ching-Kit Chen, C. Yap, C. Mattar · 2021 · Disease Models & Mechanisms
  25. Naïve-like pluripotency to pave the way for saving the northern white rhinoceros from extinction
    Vera Zywitza, Ejona Rusha, Dmitry Shaposhnikov, Jorge Ruiz‐Orera, Narasimha Swamy Telugu, Valentyna M. Rishko, Masafumi Hayashi, Geert Michel, Lars Wittler, Jan Stejskal et al. · 2022 · Scientific Reports
  26. Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?
    Dinesh Selvakumar, Leila Reyes, James J.H. Chong · 2022 · Current Cardiology Reports
  27. An in silico–in vitro pipeline for drug cardiotoxicity screening identifies ionic pro‐arrhythmia mechanisms
    Alexander P. Clark, Siyu Wei, Darshan Kalola, Trine Krogh‐Madsen, David J. Christini · 2022 · British Journal of Pharmacology
  28. PDMS–PEG Block Copolymer and Pretreatment for Arresting Drug Absorption in Microphysiological Devices
    Devin B. Mair, Marcus A. C. Williams, Jeffrey Fanzhi Chen, Alex J. Goldstein, Alex Wu, Peter H.U. Lee, Nathan J. Sniadecki, Deok‐Ho Kim · 2022 · ACS Applied Materials & Interfaces
  29. Exosomes mediated fibrogenesis in dilated cardiomyopathy through a MicroRNA pathway
    Xuebin Fu, Rachana Mishra, Ling Chen, Mir Yasir Arfat, Sudhish Sharma, Tami J. Kingsbury, Muthukumar Gunasekaran, Progyaparamita Saha, Charles C. Hong, Peixin Yang et al. · 2023 · iScience
  30. Ultrasound Mediated Polymerization for Cell Delivery, Drug Delivery, and 3D Printing
    Lior Debbi, Majd Machour, Daniel Dahis, Hagit Shoyhet, Margarita Shuhmaher, Ruth Potter, Yael Tabory, Idit Goldfracht, Itiel Dennis, Tom Blechman et al. · 2024 · Small Methods
  31. GPER mediates estrogen cardioprotection against epinephrine-induced stress
    Lu Fu, Hongyuan Zhang, Jeremiah Ong’achwa Machuki, Tingting Zhang, Lin Han, Lili Sang, Lijuan Wu, Zhiwei Zhao, Matthew James Turley, Xide Hu et al. · 2021 · Journal of Endocrinology
  32. High glucose suppresses embryonic stem cell differentiation into cardiomyocytes
    Penghua Yang, Xi Chen, Sunjay Kaushal, E. Albert Reece, Peixin Yang · 2016 · Stem Cell Research & Therapy
  33. Modeling congenital heart disease: lessons from mice, hPSC-based models, and organoids
    Kavitha S. Rao, Vasumathi Kameswaran, Benoit G. Bruneau · 2022 · Genes & Development
  34. Cell population balance of cardiovascular spheroids derived from human induced pluripotent stem cells
    Yan, Yuanwei, Bejoy, Julie, Xia, Junfei, Griffin, Kyle, Guan, Jingjiao, Li, Yan · 2019 · Scientific Reports
  35. Substrate and mechanotransduction influence SERCA2a localization in human pluripotent stem cell-derived cardiomyocytes affecting functional performance
    Sebastian Martewicz, Elena Serena, Susi Zatti, Gordon M. Keller, Nicola Elvassore · 2017 · Stem Cell Research
  36. Human Induced Pluripotent Stem Cell Production and Expansion from Blood using a Non‐Integrating Viral Reprogramming Vector
    Arun Sharma, Michael Benedikt Mücke, Christine E. Seidman · 2018 · Current Protocols in Molecular Biology
  37. Efficient differentiation of cardiomyocytes and generation of calcium-sensor reporter lines from nonhuman primate iPSCs
    Yongshun Lin, Huimin Liu, Michael G. Klein, John W. Ostrominski, So Gun Hong, Ravi Chandra Yada, Guibin Chen, Keron Navarengom, Robin Schwartzbeck, Hong San et al. · 2018 · Scientific Reports
  38. Stem Cell Therapy of Myocardial Infarction: A Promising Opportunity in Bioengineering
    Bin Jiang, Li Yan, James G. Shamul, Maxwell Hakun, Xiaoming He · 2020 · Advanced Therapeutics
  39. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege
    Yi‐Hsien Fang, Saprina P.H. Wang, Zi-Han Gao, Sheng‐Nan Wu, Hsien‐Yuan Chang, Pei-Jung Yang, Ping‐Yen Liu, Yen-Wen Liu · 2020 · International Journal of Molecular Sciences
  40. Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies
    Magali Seguret, Eva Vermersch, Charlène Jouve, Jean‐Sébastien Hulot · 2021 · Biomedicines
  41. Metabolic Determinants in Cardiomyocyte Function and Heart Regenerative Strategies
    Magda Correia, Francisco dos Santos, Rita da Silva Ferreira, Rita M. Ferreira, Bruno Bernardes de Jesus, Sandrina Nóbrega Pereira · 2022 · Metabolites
  42. Engineering stem cell therapeutics for cardiac repair
    Jun Fang, Jennifer J. Li, Xintong Zhong, Yue Zhou, Randall J. Lee, Ke Cheng, Song Li · 2022 · Journal of Molecular and Cellular Cardiology
  43. Concise Review: Fluorescent Reporters in Human Pluripotent Stem Cells: Contributions to Cardiac Differentiation and Their Applications in Cardiac Disease and Toxicity
    Sabine C. Den Hartogh, R. C. Passier · 2015 · Stem Cells
  44. From pluripotency to myogenesis: a multistep process in the dish
    Barbara Świerczek‐Lasek, Maria A. Ciemerych, Karolina Archacka · 2015 · Journal of Muscle Research and Cell Motility
  45. MicroRNA-19b Downregulates Gap Junction Protein Alpha1 and Synergizes with MicroRNA-1 in Viral Myocarditis
    Junyi Lin, Aimin Xue, Liliang Li, Beixu Li, Yuhua Li, Yiwen Shen, Ning Sun, Ruizhen Chen, Hongfei Xu, Ziqin Zhao · 2016 · International Journal of Molecular Sciences
  46. Discovery and progress of direct cardiac reprogramming
    Hidenori Kojima, Masaki Ieda · 2017 · Cellular and Molecular Life Sciences
  47. Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes
    Man Liu, Guangbin Shi, Anyu Zhou, Cassady E. Rupert, Kareen L. K. Coulombe, Samuel C. Dudley · 2018 · Journal of Molecular and Cellular Cardiology
  48. Vascularization of Engineered Spatially Patterned Myocardial Tissue Derived From Human Pluripotent Stem Cells in vivo
    Maureen Wanjare, Masashi Kawamura, Caroline Hu, Cynthia A. Alcazar, Hanjay Wang, Yi-Ping Joseph Woo, Ngan Fong Huang · 2019 · Frontiers in Bioengineering and Biotechnology
  49. Temporal Control of the WNT Signaling Pathway During Cardiac Differentiation Impacts Upon the Maturation State of Human Pluripotent Stem Cell Derived Cardiomyocytes
    Chantelle Tsoi, Ruixia Deng, Maxwell Kwok, Bin Yan, Carrie B. Lee, Hung Sing Li, Chloe Ho Yi, Ruibang Luo, Kam Tong Leung, Gcf Chan et al. · 2022 · Frontiers in Molecular Biosciences
  50. Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules
    Henning Kempf, Robert Zweigerdt · 2017 · Advances in biochemical engineering, biotechnology
  51. Efficient differentiation of human ES and iPS cells into cardiomyocytes on biomaterials under xeno-free conditions
    Tzu‐Cheng Sung, Chenghui Liu, Wei-Lun Huang, Yu-Chun Lee, Suresh S. Kumar, Yung Chang, Qing‐Dong Ling, Shih-Tien Hsu, Akon Higuchi · 2019 · Biomaterials Science
  52. Trajectory mapping of human embryonic stem cell cardiogenesis reveals lineage branch points and an ISL1 progenitor-derived cardiac fibroblast lineage
    Mimmi Mononen, Chuen Yan Leung, Jiejia Xu, Kenneth R. Chien · 2020 · Stem Cells
  53. Sodium current abnormalities and deregulation of Wnt/β-catenin signaling in iPSC-derived cardiomyocytes generated from patient with arrhythmogenic cardiomyopathy harboring compound genetic variants in plakophilin 2 gene
    Aleksandr A. Khudiakov, Anastasia K. Zaytseva, Kseniya Perepelina, Natalia Smolina, Tatiana M. Pervunina, Elena S. Vasichkina, Alexey V. Karpushev, Alexey N. Tomilin, Anna Malashicheva, Anna Aleksandrovna Kostareva · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  54. GS-967 and Eleclazine Block Sodium Channels in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
    Franck Potet, Defne E. Egecioglu, Paul W. Burridge, Alfred L. George · 2020 · Molecular Pharmacology
  55. A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine
    Pallavi Pushp, Diogo E.S. Nogueira, Carlos A. V. Rodrigues, Frederico Castelo Ferreira, Joaquim M. S. Cabral, Mukesh Kumar Gupta · 2020 · Stem Cell Reviews and Reports
  56. Effects of Cryopreservation on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles
    Joe Z. Zhang, Nadjet Belbachir, Tiejun Zhang, Yu Liu, Rajani Shrestha, Joseph C. Wu · 2020 · Stem Cell Reports
  57. Arrhythmia Mechanisms in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
    Michelangelo Paci, Kirsi Penttinen, Mari Pekkanen-Mattila, Jussi T. Koivumäki · 2020 · Journal of Cardiovascular Pharmacology
  58. Knockout of MYOM1 in human cardiomyocytes leads to myocardial atrophy via impairing calcium homeostasis
    Chengwen Hang, Yuanxiu Song, Yanan Li, Siyao Zhang, Yun Chang, Rui Bai, Amina Saleem, Mengqi Jiang, Wenjing Lu, Feng Lan et al. · 2021 · Journal of Cellular and Molecular Medicine
  59. Dextran-based scaffolds for in-situ hydrogelation: Use for next generation of bioartificial cardiac tissues
    Banerjee, Samhita, Szepes, Monika, Dibbert, Nick, Rios-Camacho, Julio-Cesar, Kirschning, Andreas, Gruh, Ina, Dräger, Gerald · 2021 · Carbohydrate Polymers
  60. Cardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy
    Ayhan Atmanli, Andreas C. Chai, Miao Cui, Zhaoning Wang, Takahiko Nishiyama, Rhonda Bassel‐Duby, Eric N. Olson · 2021 · Circulation Research
  61. Tissue Engineering Techniques for Induced Pluripotent Stem Cell Derived Three-Dimensional Cardiac Constructs
    Tori T. Salem, Zachary D. Frankman, Jared M. Churko · 2021 · Tissue Engineering Part B Reviews
  62. 1-deoxysphingolipids bind to COUP-TF to modulate lymphatic and cardiac cell development
    Ting Wang, Zheng Wang, Lauriane de Fabritus, Jinglian Tao, Essa M. Saied, Ho‐Joon Lee, Bulat R. Ramazanov, Benjamin Jackson, Daniel B. Burkhardt, Mikhail Parker et al. · 2021 · Developmental Cell
  63. Cardiac ultrastructure inspired matrix induces advanced metabolic and functional maturation of differentiated human cardiomyocytes
    Junaid M. Afzal, Yamin Liu, Wenqiang Du, Yasir Suhail, Pengyu Zong, Jianlin Feng, Visar Ajeti, Wasim A. Sayyad, Joerg Nikolaus, Maya P. Yankova et al. · 2022 · Cell Reports
  64. Human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte modelling of cardiovascular diseases for natural compound discovery
    Keyang Zhu, Xiaoming Bao, Yingchao Wang, Ting Lu, Ling Zhang · 2022 · Biomedicine & Pharmacotherapy
  65. Engineered tissue vascularization and engraftment depends on host model
    Eileen L. Brady, Olivia Prado, Fredrik Johansson, Shannon N. Mitchell, Amy Martinson, Elaheh Karbassi, Hans Reinecke, Charles E. Murry, Jennifer Davis, Kelly R. Stevens · 2023 · Scientific Reports
  66. Human induced pluripotent stem cell-derived cardiac myocytes and sympathetic neurons in disease modelling
    Ni Li, Michael J. Edel, Kun Liu, Chris N. Denning, Jacob Betts, Oliver C. Neely, Dan Li, David J. Paterson · 2023 · Philosophical Transactions of the Royal Society B Biological Sciences
  67. Integrated Manufacturing of Suspended and Aligned Nanofibrous Scaffold for Structural Maturation and Synchronous Contraction of HiPSC-Derived Cardiomyocytes
    Lingling Liu, Feng Xu, Hang Jin, Bin Qiu, Jianhui Yang, Wangzihan Zhang, Qiang Gao, Bin Lin, Songyue Chen, Daoheng Sun · 2023 · Bioengineering
  68. New treatment methods for myocardial infarction
    Bingbing Sun, Long Wang, Wenmin Guo, Shixuan Chen, Yujie Ma, Dongwei Wang · 2023 · Frontiers in Cardiovascular Medicine
  69. Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models
    Ming Dong, Wenwen Ding, Yansong Liao, Ye Liu, Dewen Yan, Yi Zhang, Rongming Wang, Na Zheng, Shuaiye Liu, Jie Liu · 2014 · European Journal of Pharmacology
  70. Engineering micromyocardium to delineate cellular and extracellular regulation of myocardial tissue contractility
    Nethika R. Ariyasinghe, Caitlin H. Reck, Alyssa A. Viscio, Andrew P. Petersen, Davi M. Lyra‐Leite, Nathan Cho, Megan Laura McCain · 2017 · Integrative Biology
  71. Engineering human ventricular heart tissue based on macroporous iron oxide scaffolds
    Hui Yang, Lai Wei, Chen Liu, Weiyi Zhong, Bin Li, Yuncan Chen, Rui Han, Jiexian Zhuang, Jianxun Qu, Hongyue Tao et al. · 2019 · Acta Biomaterialia
  72. The Use of iPSC-Derived Cardiomyocytes and Optical Mapping for Erythromycin Arrhythmogenicity Testing
    A. D. Podgurskaya, V. A. Tsvelaya, М. М. Slotvitsky, Elena Vladimirovna Dementyeva, Kamila R. Valetdinova, Агладзе Константин Игоревич · 2019 · Cardiovascular Toxicology
  73. Human Cardiac Fibroblast Number and Activation State Modulate Electromechanical Function of hiPSC-Cardiomyocytes in Engineered Myocardium
    Cassady E. Rupert, Tae Yun Kim, Bum‐Rak Choi, Kareen L. K. Coulombe · 2020 · Stem Cells International
  74. CRISPR/Cas9-based targeting of fluorescent reporters to human iPSCs to isolate atrial and ventricular-specific cardiomyocytes
    Orlando Chirikian, William Rowland Goodyer, Elda Dzilic, Vahid Serpooshan, Jan Willem Buikema, Wesley L. McKeithan, Haodi Wu, Guang Li, Soah Lee, Markus W. Merk et al. · 2021 · Scientific Reports
  75. LMNA-related cardiomyopathy: From molecular pathology to cardiac gene therapy
    Ze Wang, Jiahao Wu, Zhengyuan Lv, Ping Liang, Qirui Li, Yifei Li, Yuxuan Guo · 2025 · Journal of Advanced Research
  76. Concise Review: Growing Hearts in the Right Place: On the Design of Biomimetic Materials for Cardiac Stem Cell Differentiation
    Yohan Farouz, Yong Chen, André Terzic, Philippe Menasché · 2014 · Stem Cells
  77. Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells
    Aaron J. Velasquez-Mao, Christopher Tsao, Madeline N. Monroe, Xavier D. Legras, Beatrice Bissig-Choisat, Karl‐Dimiter Bissig, Rodrigo Ruano, Jeffrey G. Jacot · 2017 · PLoS ONE
  78. CXCR4 and CXCR7 play distinct roles in cardiac lineage specification and pharmacologic β-adrenergic response
    Delaine K. Ceholski, Irene C. Turnbull, Venu Pothula, Laura Lecce, Andrew A. Jarrah, Changwon Kho, Ahyoung Lee, Lahouaria Hadri, Kevin D. Costa, Roger J. Hajjar et al. · 2017 · Stem Cell Research
  79. Harnessing cell pluripotency for cardiovascular regenerative medicine
    Haodong Chen, Angela Zhang, Joseph C. Wu · 2018 · Nature Biomedical Engineering
  80. Cardiac regeneration with pluripotent stem cell-derived cardiomyocytes and direct cardiac reprogramming
    Taketaro Sadahiro · 2019 · Regenerative Therapy
  81. Adeno-associated virus-mediated gene delivery promotes S-phase entry-independent precise targeted integration in cardiomyocytes
    Yasuaki Kohama, Shuichiro Higo, Yuki Masumura, Mikio Shiba, Takumi Kondo, Takamaru Ishizu, Tomoaki Higo, Satoki Nakamura, Satoshi Kameda, Tomoka Tabata et al. · 2020 · Scientific Reports
  82. Aortic “Disease-in-a-Dish”: Mechanistic Insights and Drug Development Using iPSC-Based Disease Modeling
    Hongorzul Davaapil, Deeti K. Shetty, Sanjay Sinha · 2020 · Frontiers in Cell and Developmental Biology
  83. Multiomics Method Enabled by Sequential Metabolomics and Proteomics for Human Pluripotent Stem-Cell-Derived Cardiomyocytes
    Elizabeth F. Bayne, Aaron D. Simmons, David S. Roberts, Yanlong Zhu, Timothy J. Aballo, Benjamin Wancewicz, Sean P. Palecek, Ying Ge · 2021 · Journal of Proteome Research
  84. Losartan protects human stem cell-derived cardiomyocytes from angiotensin II-induced alcoholic cardiotoxicity
    Yuanxiu Song, Hongxia Li, Shuhong Ma, Min Zhu, Wenjing Lü, Feng Lan, Ming Cui · 2022 · Cell Death Discovery
  85. Novel method of differentiating human induced pluripotent stem cells to mature cardiomyocytes via Sfrp2
    Ying‐Chang Hsueh, Richard E. Pratt, Victor J. Dzau, Conrad P. Hodgkinson · 2023 · Scientific Reports
  86. Harnessing the Induction of Cardiomyocyte Proliferation for Cardiac Regenerative Medicine
    Arun Sharma, Yuan Zhang, Sean M. Wu · 2015 · Current Treatment Options in Cardiovascular Medicine
  87. Clinical‐scale purification of pluripotent stem cell derivatives for cell‐based therapies
    Gonçalo M. C. Rodrigues, Carlos A. V. Rodrigues, Tiago G. Fernandes, M. M. Diogo, J. M. Cabral · 2015 · Biotechnology Journal
  88. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp
    Stefan A. Mann, Juliane Heide, Thomas Knott, Razvan Airini, Florin Bogdan Epureanu, Alexandru‐Florian Deftu, Antonia Teona Deftu, Beatrice Mihaela Radu, Bogdan P. Amuzescu · 2019 · Journal of Pharmacological and Toxicological Methods
  89. In vitro models of neuromuscular junctions and their potential for novel drug discovery and development
    Olaia F. Vila, Yihuai Qu, Gordana Vunjak‐Novakovic · 2019 · Expert Opinion on Drug Discovery
  90. Comparative Transcriptome Landscape of Mouse and Human Hearts
    Tatsuya Anzai, Takanori Yamagata, Hideki Uosaki · 2020 · Frontiers in Cell and Developmental Biology
  91. Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy
    Joshua K. Meisner, Aaron Renberg, Eric D. Smith, Yao-Chang Tsan, Brynn Elder, Abbey Bullard, Owen L. Merritt, Sean Lee Zheng, Neal K. Lakdawala, ANJALI TIKU OWENS et al. · 2024 · Circulation
  92. Human induced pluripotent stem cell line with genetically encoded fluorescent voltage indicator generated via CRISPR for action potential assessment post-cardiogenesis
    Yaohui Sun, Hillary K.J. Kao, Che-Wei Chang, Alexander A. Merleev, James L. Overton, Dalyir I. Pretto, Sergey Yechikov, Emanual Michael Maverakis, Nipavan Chiamvimonvat, James W. Chan et al. · 2019 · Stem Cells
  93. MRAS Variants Cause Cardiomyocyte Hypertrophy in Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Erin M. Higgins, Johan Martijn Bos, Steven Michael Dotzler, CS John Kim, Michael John Ackerman · 2019 · Circulation Genomic and Precision Medicine
  94. Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models
    Joseph Kwong‐Leung Yu, Jialiu A. Liang, William H. Franceschi, Qinwen Huang, Farhad Pashakhanloo, Eric Sung, Patrick M. Boyle, Natalia A. Trayanova · 2021 · Cardiovascular Research
  95. LncRNA HBL1 is required for genome-wide PRC2 occupancy and function in cardiogenesis from human pluripotent stem cells
    Juli Liu, Sheng Liu, Lei Han, Yi Sheng, Yucheng Zhang, Il‐man Kim, Jun Wan, Lei Yang · 2021 · Development
  96. Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human Cardiomyocytes
    Nils Bömer, Mario Pávez, Frederik Ernst Deiman, Annet N. Linders, Martijn F. Hoes, Christiane L.J. Baierl, Silke U. Oberdorf‐Maass, Rudolf A. de Boer, Herman H.W. Silljé, Eugène Berezikov et al. · 2021 · International Journal of Molecular Sciences
  97. Cardiac regeneration: Options for repairing the injured heart
    Jun Wang, Meilin An, Bernhard Johannes Haubner, Josef Martin Penninger · 2023 · Frontiers in Cardiovascular Medicine
  98. Prevascularized, multiple-layered cell sheets of direct cardiac reprogrammed cells for cardiac repair
    Seuk Young Song, Hyeok Kim, Jin Ho Yoo, Sung Pil Kwon, Bong‐Woo Park, Jin-Ju Kim, Kiwon Ban, Kookheon Char, Hun‐Jun Park, Byung‐Soo Kim · 2020 · Biomaterials Science
  99. Perspective on human pluripotent stem cell-derived cardiomyocytes in heart disease modeling and repair
    Qiang Li, Jia Wang, Qiang Wu, Nan Cao, Huang‐Tian Yang · 2020 · Stem Cells Translational Medicine
  100. Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping
    Peipei Wang, Philip L. Bailin, Mandi Zhu, Rena Y. Han, Shuliang Guo, Renzhi Han · 2022 · Molecular Therapy — Methods & Clinical Development